Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4FN
|
||||
Former ID |
DNC006228
|
||||
Drug Name |
2pyrrolidin-1-yl-1-phenylpentan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528036] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H21NO
|
||||
Canonical SMILES |
CCCC(C(=O)C1=CC=CC=C1)N2CCCC2
|
||||
InChI |
1S/C15H21NO/c1-2-8-14(16-11-6-7-12-16)15(17)13-9-4-3-5-10-13/h3-5,9-10,14H,2,6-8,11-12H2,1H3
|
||||
InChIKey |
YDIIDRWHPFMLGR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [528036] | |
Sodium-dependent dopamine transporter | Target Info | Inhibitor | [528036] | ||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
WikiPathways | Monoamine Transport | ||||
NRF2 pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport | |||||
Dopaminergic Neurogenesis | |||||
Parkinsons Disease Pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.